Guy Goodwin


Guy Goodwin
University of Oxford, Oxford, UK

Guy Goodwin, DPhil, FMedSci is currently Senior Research Fellow at the University of Oxford, Oxford, UK. He completed his medical degree and DPhil in physiology at the University of Oxford and, following his training in psychiatry, became a Clinical Scientist and Consultant Psychiatrist at the MRC Brain Metabolism Unit at the Royal Edinburgh Hospital, Edinburgh, UK. He was from 1996 to 2014 WA Handley Professor of Psychiatry, University of Oxford where he was head of the department of psychiatry from 1996 to 2011.

His research interests are in the treatment of bipolar disorder and the application of neuroscience in understanding the neurobiology of mood disorders, with a focus on developing new treatments. He has been a lead investigator in clinical trials for bipolar affective disorder, including the BALANCE and CEQUEL studies. He is lead author of the British Association for Psychopharmacology (BAP) guideline group for treatment of Bipolar Disorder, the third edition of which will be published in 2016. He works with industry in developing translational models of psychotropic drug action in man. Finally he is leading research on the monitoring of unstable mood states using patient reported outcomes and physical sensors. For the development of the TrueColours platform, his research team won the NHS Live Innovation award and in 2009, he won the Mogens Schou Award for Research at the bipolar international meeting in Pittsburgh.

He has served as a member of the Wellcome Trust Neurosciences Panel, the Council of the British Association for Psychopharmacology, the Clinical Fellowships Panel and Advisory Board of the Medical Research Council, INSERM's ANR panel. He is a Fellow of the American College of Neuropsychopharmacology, and has previously held the position of President of the British Association for Psychopharmacology (2004–2005). He is president of the European College of Neuropsychopharmacology (ECNP, 2013-2016) and a Senior Investigator on the faculty of UK National Institute for Health Research (NIHR 2011-17). He represents ECNP on the European Brain Council (EBC).

⇐ Back to the Home